openPR Logo
Press release

Estrogen Receptor-Positive Breast Cancer - Key Players Analysis Eli Lilly and Company, Genentech, Radius Health, Inc.

11-26-2018 10:55 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: P&S Intelligence

Estrogen Receptor-Positive Breast Cancer - Key Players

The study analyzed that the estrogen receptor positive breast cancer pipeline comprises approximately 74 drug candidates in different stages of development.

Download report sample at: https://www.psmarketresearch.com/market-analysis/estrogen-receptor-positive-breast-cancer-pipeline-analysis/report-sample

*Major companies collaborate for the development of ER+ breast cancer pipeline

The research finds that different companies have collaborated for the development of ER+ breast cancer. In January 2016, Radius Health, Inc. entered in a worldwide clinical collaboration with Novartis Pharmaceuticals to evaluate the safety and efficacy of combining investigational agent RAD1901 with LEE011 for advanced breast cancer.

Pre-Purchase Inquiry at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=estrogen-receptor-positive-breast-cancer-pipeline-analysis

Some of the key players developing drugs for Estrogen Receptor-Positive (ER+) breast cancer are Chipscreen Biosciences, Ltd., Eli Lilly & Company, Genentech, Inc., and others.

*Chemical Genomics-Based Discovery Platform for ER+ breast cancer drug development

Chipscreen Biosciences, Ltd. is using chemo genomics approach for the development of their drug candidates in ER+ breast cancer. The approach connects small molecule structures to disease targets and therapeutic functions to accelerate the discovery process by effectively comparing the molecular profiles of successful drugs, failed drugs, and classical toxins.

Browse report at: https://www.psmarketresearch.com/market-analysis/estrogen-receptor-positive-breast-cancer-pipeline-analysis

About P&S Intelligence

P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

Contact:
P&S Intelligence
347 5th Ave. #1402- 210
New York City, NY 10016 United States
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Estrogen Receptor-Positive Breast Cancer - Key Players Analysis Eli Lilly and Company, Genentech, Radius Health, Inc. here

News-ID: 1400046 • Views:

More Releases from P&S Intelligence

U.S. ESG Investments Market Set to Skyrocket: $16 Trillion by 2032
U.S. ESG Investments Market Set to Skyrocket: $16 Trillion by 2032
According to the latest market research study published by P&S Intelligence, the U.S. Environmental, Social, and Governance (ESG) investments market is experiencing a significant surge, with projections indicating an increase from $6.5 trillion in 2024 to an estimated $16.0 trillion by 2032. This represents a robust compound annual growth rate (CAGR) of 12.1% over the forecast period. According to a comprehensive analysis by P&S Intelligence, the market's expansion is driven
Facility Management in the U.K. Booms with 14.1% CAGR as Demand Soars Across Sectors
Facility Management in the U.K. Booms with 14.1% CAGR as Demand Soars Across Sec …
According to the latest market research study published by P&S Intelligence, the U.K. facility management market is poised for significant growth, with projected revenues reaching USD 2,743.3 million in 2024 and expected to soar to USD 6,038.4 million by 2030, reflecting a robust CAGR of 14.1% during the forecast period. This expansion is fueled by a surge in demand across both public and private sectors. According to the RICS U.K.
Point-of-Sale Software Market in the U.S. Set to Grow by 9.7% CAGR, Boosted by Omnichannel Integration
Point-of-Sale Software Market in the U.S. Set to Grow by 9.7% CAGR, Boosted by O …
According to the latest market research study published by P&S Intelligence, the U.S. point-of-sale (POS) software market, valued at USD 4.7 billion in 2024, is poised for significant growth over the coming years, with projections estimating it will reach USD 9.8 billion by 2032, expanding at a compound annual growth rate (CAGR) of 9.7%. This growth is attributed to rapid technological advancements, a surge in mobile and cloud-based POS systems,
Competitive Landscape of the Industrial Starches Market: Key Players, Trends, and Growth Opportunities
Competitive Landscape of the Industrial Starches Market: Key Players, Trends, an …
According to the latest market research study published by P&S Intelligence, the global industrial starches market is poised for significant growth, with a projected increase from USD 110.3 billion in 2024 to USD 169.9 billion by 2030, at a robust compound annual growth rate (CAGR) of 7.5%. Industrial starches play a crucial role in diverse sectors, including food, pharmaceuticals, and paper, driven by their unique properties such as stabilizing, thickening,

All 4 Releases


More Releases for ER+

ER+/HER2- Breast Cancer Market Insights and Future Outlook
Introduction Estrogen receptor-positive, HER2-negative (ER+/HER2-) breast cancer is the most common molecular subtype of breast cancer, accounting for nearly 70% of all breast cancer diagnoses worldwide. This classification is defined by tumors that express estrogen receptors (ER) but lack human epidermal growth factor receptor 2 (HER2) amplification. The subtype's dominance in global oncology has positioned it as the central focus for therapeutic innovation, guidelines development, and precision medicine strategies. Historically managed with
Er YAG Laser Market Outlook and Future Projections for 2030
An Er:YAG laser (erbium-doped yttrium aluminum garnet) is a type of solid-state laser commonly used in medical and cosmetic procedures. It emits light at a wavelength of 2940 nm, which is highly absorbed by water, making it effective for precise tissue ablation and resurfacing. This laser is popular in dermatology and dentistry for its ability to gently remove layers of skin or tissue with minimal thermal damage and quick healing. The
Optical Brightener ER-I and ER-II Market Size Unveiled: Trends and Projections
The global Optical Brightener ER-I and ER-II market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Optical Brightener ER-I and ER-II market. For instance, the market dynamics section digs deep into the drivers, restraints,
Optical Brightener ER-I and ER-II Market by Key Players,Competitive landscape an …
LOS ANGELES, United States: The global Optical Brightener ER-I and ER-II market is analyzed in quite some detail in the report with a strong focus on the competitive landscape, segmentation, market dynamics, and regional market expansion. The report includes a thorough assessment of the business of key players operating in the global Optical Brightener ER-I and ER-II market. With deeper qualitative and quantitative analysis of the global Optical Brightener ER-I and
Optical Brightener ER-I and ER-II Market Trends, Regional Overview, Leading Comp …
LOS ANGELES, United States: The global Optical Brightener ER-I and ER-II market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Optical Brightener ER-I and ER-II market. For instance, the market dynamics section digs deep
ER Wagner adding 600-ton Servo Punch Press
Milwaukee-based ER Wagner announced it will have a new 600-ton Servo Punch Press available for production in late 2017, greatly increasing ER Wagner’s metal stamping capabilities. The Nidec Minster Corporation machine, which will be a part of ER Wagner’s new 157,000-square-foot corporate headquarters and state of the art manufacturing facility currently under construction in the Village of Menomonee Falls, Wis., is latest technology in metal stamping, giving the company the ability